In another study, estrogen therapy reduced the serum levels of IL-6, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) in postmenopausal women with type 2 diabetes compared with levels in the placebo-treated group [181]. The gene discussed is GPT; the disease is type 2 diabetes mellitus.